Device Trial Radar · NCT07121933
Evaluation of Erchonia PPL Laser as a Pretreatment Adjunct to Enhance Standard Erchonia Red Laser for the Relief of Pain
Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Aug 20, 2025
Primary completion
Mar 26, 2026
Study completion Mar 28, 2026
Sponsor
- Lead sponsor
- Erchonia CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 14, 2025
Design
- Study type
- Interventional
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to see if applying pre-treatment with the Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy can help reduce nociceptive musculoskeletal pain
Conditions
- Musculoskeletal Pain
Interventions
Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapyDevice
450 nanometers (nm) blue dual-diode laser application followed by 640nm red laser application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With 30% or Greater Change in Pain Rating on the Visual Analog Scale (VAS)Time frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Laser Chiropractic
West Covina, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.